The clinical pharmacokinetics of zolmitriptan

Cephalalgia

Volumn 17, Issue 18_suppl, 1997, Pages 15-20

  Dixon, R ^a   Warrander, A ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

5HT 1B 1D receptor agonist; pharmacokinetics; Zolmitriptan

Indexed keywords

ZOLMITRIPTAN;

AGE; ANALYTIC METHOD; AREA UNDER THE CURVE; ARTICLE; DISEASE ASSOCIATION; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; HUMAN; LIVER FAILURE; MAXIMUM PLASMA CONCENTRATION; SEX DIFFERENCE; TIME TO MAXIMUM PLASMA CONCENTRATION; URINARY EXCRETION; AGED; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; FEMALE; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION;

ABSORPTION; ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; LIVER DISEASES; MALE; MIGRAINE DISORDERS; OXAZOLES; OXAZOLIDINONES; SEROTONIN AGONISTS; TISSUE DISTRIBUTION; TRYPTAMINES;

EID: 0030859745     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102497017S1803     Document Type: Article

References (22)

1. 1B/1D receptor agonists. Neurology 1997; 48 Suppl 3: S21-24
2. Goadsby PJ, Edvinsson L., Peripheral and central trigeminovascular activation in cat is blocked by the serotonin (5HT)-1D receptor agonist 311C90. Headache 1994; 34: 394-9
3. Knight YE, Goadsby PJ., Central nervous system distribution of (3H)-311C90 in cat. Cephalalgia 1995; 15 Suppl 14: 214 (Abs)
4. Mills A, Rhodes P, Martin GR., (3H)311C90 binding sites in cat brain stem: implications for migraine treatment. Cephalalgia 1995; 15 Suppl 14: 116 (Abs)
5. 1D agonist. Front Headache Res 1997; 6: 243-51
6. Tokola RA, Neuvonen PJ., Effect of migraine attacks on paracetamol absorption. Br J Clin Pharmacol 1984; 18: 867-71
7. Seaber E, On N, Phillips S, Churchus R, Posner J, Rolan P., The tolerability and pharmacokinetics of the novel antimigraine compound 311C90 in healthy male volunteers. Br J Clin Pharmacol 1996; 41: 141-7
8. Dixon R, Gillotin C, Gibbens M, Posner J, Peck RW., The pharmacokinetics and effects on blood pressure of multiple doses of the novel antimigraine drug, zolmitriptan (311C90) in healthy volunteers. Br J Clin Pharmacol 1997; 43: 273-81
9. Dixon R., The pharmacokinetics and effect of food on the absorption of 311C90 (Zomig) in healthy volunteers. European Federation of Neurological Societies, June 4-8, 1997 (Abs)
10. Lacey LF, Hussey EK, Fowler P., Single dose pharmacokinetics of sumatriptan in healthy volunteers. Eur J Clin Pharmacol 1995; 47: 543-8
11. Seaber E, On N, Dixon RM, Gibbens M, Leavens WJ, Liptrot J, et al. The absolute bioavailability and metabolic disposition of the novel antimigraine compound zolmitriptan (311C90). Br J Clin Pharmacol 1997 (in press)
12. Dixon R, On N, Posner J., Oral bioavailability of the novel 5HT1D agonist, 311C90 (abstract). Cephalalgia 1995; 15 Suppl 14: 218 (Abs P16)
13. ∗), a novel centrally and peripheral acting oral 5-hydroxytryptamine-1D agonist: a comparison of its absorption during a migraine attack and in a migraine-free period. Cephalalgia 1996; 16: 270-5
14. Goadsby PJ, Edvinsson L., Peripheral and central trigeminovascular activation in cat is blocked by the serotonin (5HT)-1D receptor agonist 311C90. Headache 1994; 34: 394-9
15. Goadsby PJ, Knight YE., Direct evidence for central sites of action of zolmitriptan (311C90) an autoradiographic study in cat. Cephalalgia 1997; 17: 153-8
16. Schoenen J, Proietti A, Afra J, Peck RW., Further characterization of pre-clinical 311C90 profile in man: CNS effects assessed with neurophysiological methods. 3rd European Headache Conference, Sardinia June 5-8, 1996. Extended abstract of an official symposium: 311C90: Potential for improving patient care, 6 June, 1996
17. Dixon CM, Park GR, Tarbit MH., Characterization of the enzyme responsible for the metabolism of sumatriptan in human liver. Biochem Pharmacol 1994; 47: 1253-7
18. Rolan PE., Potential drug interactions with the novel antimigraine compound zolmitriptan (311C90, Zomig). Cephalalgia 1997; 17 Suppl 18: 21-7
19. 1B/1D agonist: an overview of efficacy. Cephalalgia 1997; 17 Suppl 18: 28-40
20. Loder E., Clinical response to zolmitriptan ("Zomig") in migraine associated with menses, delayed treatment of migraine, migraine with aura and migraine upon awakening. Abstract and poster presented at the Diamond Headache Seminar, Orlando, July 1997. Headache Q 1997. In press
21. Seaber E, On N, Jackson S, Dixon R, Watt H, Posner J., Similar pharmacokinetics and tolerability of the novel antimigraine compound 311C90 in young and elderly volunteers. Cephalalgia 1995; 15 Suppl 14: 216 (Abs)
22. Pugh RNH, Murray-Lion IM, Dawson JL, Pietroni MC, Williams R., Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 289-96